Pharmical: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharmical
Largest movements
- Receivables within one year -€91,684
down €91,684 (-100.0%), from €91,684 to €0
- Tangible fixed assets -€17,000
down €17,000 (-5.4%), from €314,593 to €297,593
- Other debts -€130,885
down €130,885 (-39.4%), from €332,219 to €201,334
- Reserves +€98,170
up €98,170 (+857.9%), from €11,443 to €109,612
- Debts after one year -€66,751
down €66,751 (-6.9%), from €964,651 to €897,900
- Financial charges -€23,450
down €23,450 (-46.3%), from €50,598 to €27,148
of which Financial charges: -€23,450
- Depreciation -€21,186
down €21,186 (-55.5%), from €38,186 to €17,000
- Financial income +€2,638
up €2,638 (+2.9%), from €91,684 to €94,322
- Gross operating margin -€1,338
down €1,338 (-2.7%), from €49,742 to €48,404
- Other operating charges -€967
down €967 (-70.4%), from €1,375 to €408
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,579,532 | €1,481,325 | -€98,207 | -6.2% |
| Fixed assets | 21/28 | €1,471,680 | €1,454,680 | -€17,000 | -1.2% |
| Tangible fixed assets | 22/27 | €314,593 | €297,593 | -€17,000 | -5.4% |
| Land and buildings | 22 | €314,593 | €297,593 | -€17,000 | -5.4% |
| Financial fixed assets | 28 | €1,157,087 | €1,157,087 | = | 0.0% |
| Current assets | 29/58 | €107,852 | €26,645 | -€81,207 | -75.3% |
| Amounts receivable within one year | 40/41 | €91,684 | €0 | -€91,684 | -100.0% |
| Other amounts receivable | 41 | €91,684 | €0 | -€91,684 | -100.0% |
| Cash at bank and in hand | 54/58 | €16,168 | €26,645 | +€10,477 | +64.8% |
| Total equity and liabilities | 10/49 | €1,579,532 | €1,481,325 | -€98,207 | -6.2% |
| Equity | 10/15 | €211,443 | €309,612 | +€98,170 | +46.4% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Reserves | 13 | €11,443 | €109,612 | +€98,170 | +857.9% |
| Distributable reserves | 133 | €11,443 | €109,612 | +€98,170 | +857.9% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €1,368,089 | €1,171,713 | -€196,376 | -14.4% |
| Amounts payable after more than one year | 17 | €964,651 | €897,900 | -€66,751 | -6.9% |
| Financial debts | 170/4 | €964,651 | €897,900 | -€66,751 | -6.9% |
| Amounts payable within one year | 42/48 | €397,708 | €268,085 | -€129,623 | -32.6% |
| Current portion of amounts payable after more than one year | 42 | €64,900 | €66,751 | +€1,850 | +2.9% |
| Financial debts | 43 | €0 | - | = | |
| Credit institutions | 430/8 | €0 | - | = | |
| Trade debts | 44 | €588 | €0 | -€588 | -100.0% |
| Suppliers | 440/4 | €588 | €0 | -€588 | -100.0% |
| Other amounts payable | 47/48 | €332,219 | €201,334 | -€130,885 | -39.4% |
| Accrued charges and deferred income | 492/3 | €5,731 | €5,728 | -€3 | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €38,186 | €17,000 | -€21,186 | -55.5% |
| Other operating charges | 640/8 | €1,375 | €408 | -€967 | -70.4% |
| Gross operating margin | 9900 | €49,742 | €48,404 | -€1,338 | -2.7% |
| Operating profit (loss) | 9901 | €10,181 | €30,996 | +€20,815 | +204.5% |
| Financial income | 75/76B | €91,684 | €94,322 | +€2,638 | +2.9% |
| Recurring financial income | 75 | €91,684 | €94,322 | +€2,638 | +2.9% |
| Financial charges | 65/66B | €50,598 | €27,148 | -€23,450 | -46.3% |
| Recurring financial charges | 65 | €50,598 | €27,148 | -€23,450 | -46.3% |
| Non-recurring financial charges | 66B | €0 | - | = | |
| Profit (loss) for the period before taxes | 9903 | €51,267 | €98,170 | +€46,903 | +91.5% |
| Profit (loss) for the period | 9904 | €51,267 | €98,170 | +€46,903 | +91.5% |
| Profit (loss) for the period to be appropriated | 9905 | €51,267 | €98,170 | +€46,903 | +91.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.